Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Avalo’s phase 2 skin disease win fuels pursuit of AbbVie despite placebo headwind

Avalo’s phase 2 skin disease win fuels pursuit of AbbVie despite placebo headwind

  • May 6, 2026

The placebo-adjusted result fell short of the bar set by Avalo, analysts and AbbVie’s rival program, but the biotech’s stock jumped in premarket trading.

Leave A Comment

Fields (*) Mark are Required